Thirteen more families have filed suit against Pfizer, Inc., the manufacturer of the SSRI antidepressant drug Zoloft, and its subsidiary Roerig. The lawsuits claim birth defects suffered by plaintiff’s minor children were caused by taking Zoloft during pregnancy pursuant to doctor’s directions. Greenstone, LLC, the manufacturer of the generic version of Zoloft (sertraline), also was named in the suits.
The suits join several other lawsuits filed in the Wayne County Circuit Court of West Virginia, Judge James H. Young, Jr. presiding. These cases are separate from the Zoloft Multidistrict litigation (MDL) that currently is pending in Federal District Court for the Eastern District of Pennsylvania in Philadelphia, PA.
The plaintiffs make several claims in the pending actions. They claim that Pfizer knew or should have known about the risks to unborn fetuses associated with taking Zoloft during pregnancy. Further, they state that Zoloft is a defective drug; dangerous to human health; unfit and unsuitable to be marketed and sold; and lacks the proper warnings as to the dangers associated with its use.
Each minor child named in the lawsuits claims to have suffered a congenital birth defect as a direct result of exposure to Zoloft in utero. These include atrial septal defects (ASD), multiple holes in the heart, persistent pulmonary hypertension of the newborn (PPHN), neural tube defects, craniofacial defects and other malformations.
Plaintiffs in the Zoloft lawsuits are seeking compensatory and punitive damages with pre and post judgment interest.